Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Response to Jabalameli

Genes & Immunity volume 12, page 156 (2011)Cite this article

Subjects

We are very pleased to know that our results have been object of interest, although we would like to clarify some details. First, the Introduction of our paper1 indicates the selection basis of the single-nucleotide polymorphisms genotyped: ‘Two of them were previously associated with IBD: rs744166… and rs12948909. The other two were analyzed on the basis of their suggestive associations with more than one disease in the publicly available data of the GWAS performed by the Wellcome Trust Case-Control Consortium, although they did not exceed the threshold of statistical significance.’ The hypothesis driving this selection was to test whether STAT3 joined the group of genes showing shared susceptibility to different immune-mediated diseases.

This is a preview of subscription content, access via your institution

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

Buy

All prices are NET prices.

References

  1. Cénit MC, Alcina A, Márquez A, Mendoza JL, Díaz-Rubio M, de las Heras V et al. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun 2010; 11: 264–268.

    Article  Google Scholar 

  2. De Jager PL, Jia X, Wang J, de Bakker PI, Ottoboni L, Aggarwal NT et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat Genet 2009; 41: 776–782.

    Article  CAS  Google Scholar 

  3. International Multiple Sclerosis Genetics Consortium Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007; 357: 851–862.

    Article  Google Scholar 

  4. Baranzini SE, Wang J, Gibson RA, Galwey N, Naegelin Y, Barkhof F et al. Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. Hum Mol Genet 2009; 18: 767–778.

    Article  CAS  Google Scholar 

  5. Jakkula E, Leppä V, Sulonen AM, Varilo T, Kallio S, Kemppinen A et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010; 86: 285–291.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology, Hospital Clinico San Carlos, Madrid, Spain

    E Urcelay

Authors
  1. E Urcelay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E Urcelay.

Ethics declarations

Competing interests

The author declares no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Urcelay, E. Response to Jabalameli. Genes Immun 12, 156 (2011). https://doi.org/10.1038/gene.2010.60

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2010.60

Search

Advanced search

Quick links